Evidence map›Paper›PMID 40090673›Full record

ArticleLupus science & medicine2025

Levels of physical activity in a large international cohort of patients with systemic lupus erythematosus.

Timothée Mischler, Lou Kawka, Juan C Sarmiento-Monroy, Philippe Mertz, Luc Pijnenburg, Marina Rinagel, Manuel Francisco Ugarte-Gil, Sophie Geneton, Julien Blaess, Matteo Piga and 2 more

Abstract read
In one paragraph

Article in Lupus science & medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Timothée MischlerDepartment of Rheumatology, National Reference Center for Autoimmune Disease (RESO), Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Lou KawkaDepartment of Rheumatology, National Reference Center for Autoimmune Disease (RESO), Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Juan C Sarmiento-MonroyDepartment of Rheumatology, Hospital Clinic, Barcelona, Spain.
Philippe MertzDepartment of Rheumatology, National Reference Center for Autoimmune Disease (RESO), Hôpitaux Universitaires de Strasbourg, Strasbourg, France.ORCID 0000-0002-9781-7388
Luc PijnenburgDepartment of Rheumatology, National Reference Center for Autoimmune Disease (RESO), Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Marina RinagelDepartment of Rheumatology, National Reference Center for Autoimmune Disease (RESO), Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Manuel Francisco Ugarte-GilGrupo Peruano de Estudio de Enfermedades Autoinmunes Sistémicas, Universidad Cientifica del Sur, Lima, Peru.ORCID 0000-0003-1728-1999
Sophie GenetonDepartment of Rheumatology, National Reference Center for Autoimmune Disease (RESO), Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Julien BlaessDepartment of Rheumatology, National Reference Center for Autoimmune Disease (RESO), Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Matteo PigaDepartment of Medical Sciences and Public health, University of Cagliari, Cagliari, Italy.ORCID 0000-0002-1126-8315
Christelle SordetDepartment of Rheumatology, National Reference Center for Autoimmune Disease (RESO), Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Laurent ArnaudDepartment of Rheumatology, National Reference Center for Autoimmune Disease (RESO), Hôpitaux Universitaires de Strasbourg, Strasbourg, France laurent.arnaud@chru-strasbourg.fr.ORCID 0000-0002-8077-8394

Funding

NCIPC CDC HHS U17 CE002021
6 · The paper itself

Abstract

introductionPhysical activity (PA) holds a pivotal role in the improvement of mental health or depressive symptoms, as well as in the prevention of cardiovascular diseases (CVDs). Patients with SLE are exposed to an increased risk of CVDs and suffer from deteriorated quality of life compared with the general population. The aim of this study was to assess PA level and characteristics in a large international cohort of patients with SLE.

methodsPA was assessed in metabolic equivalent of tasks (METs) using the International Physical Activity Questionnaire (IPAQ) and classified into three levels: low, moderate and high PA. Other data such as fatigue, disease activity, pain, insomnia, anxiety, depression, stress and fibromyalgia were collected using validated patient-reported instruments, using the Lupus Expert system for the Assessment of Fatigue (LEAF) digital tool.

results1029 LEAF participants with SLE (986 (95.8%) women) with a median age of 43 years were analysed. The median physical expenditure was 936 METs/week (IQR: 297-2622). 456 (44.3%) participants were classified as having low PA levels. Increased fatigue according to the Functional Assessment of Chronic Illness Therapy-Fatigue Scale (p<0.0001), the Multidimensional Fatigue Inventory (p<0.0001), Visual Analogue Scale for fatigue (p=0.02), pain (p=0.009), depression (p=0.02) and stress (p<0.0001) were significantly more prevalent in less active patients, in IPAQ classification.

conclusionIn this large international study, more than 40% of patients with SLE were not active enough. We found an inverse association between PA levels and fatigue, pain, stress or depression. This points out the necessity to better assess PA in patients with SLE, as well as the aforementioned comorbidities to improve quality of life and reduce cardiovascular risk.

Indexed as

ExerciseLupus Erythematosus, SystemicAdultAnxietyCardiovascular DiseasesCohort StudiesDepressionFatigueFemaleHumansMaleMiddle AgedQuality of LifeSurveys and QuestionnairesOutcome Assessment, Health CareQuality of LIfeSystemic Lupus Erythematosus

Identifiers

PMID40090673
PMCPMC11911810

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.